Samsung Medical Center, Department of surgery
Seoul, South Korea
NCT Number: NCT00744159
This study aimed to clarify existence of immunological benefit of laparoscopic colon cancer surgery compared to open colon surgery.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Observational
Seoul, South Korea
Patients with clinical stage Ⅲ left colon and upper rectal cancer were prospectively assigned to undergo LC (n=35) or OC (n=39). Factors related to cellular immunity of host (total lymphocyte count, CD4 lymphocyte, CD8 lymphocyte, CD4/CD8 ratio, HLA-DR expression on monocyte (mHLA-DR)) were examined preoperatively, on the 1st day of operation (POD1) and the 5th day of operation (POD5).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: post OP 5th day
Time frame: POD 7th days
Samsung Medical Center
Other
Prospective Comparative Study of Immunological Benefit Between Laparoscopic Colectomy and Open Colectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06724185
Common Cold, Immunity
Taichung, Taiwan
View Trial DetailsNCT07070180
Adverse Childhood Experience, Anxiety Disorders
Bratislava, Slovakia
View Trial DetailsNCT06588530
Actinomycetales Infections, Adult
Paulsboro, New Jersey, United States
View Trial DetailsNCT06574685
Dry Eye Disease, Dry Eye Syndromes
Cheras, Kuala Lumpur, Malaysia
View Trial Details